I
Inovio Pharmaceuticals, Inc. (INO)
NCM – Real Time Price. Currency in USD
1.10
+0.02 (1.85%)
At close: Jun 26, 2026, 4:00 PM EDT
1.09
-0.01 (-0.91%)
After-hours: Jun 26, 2026, 7:54 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.10
+0.02 (1.85%)
At close: Jun 26, 2026, 4:00 PM EDT
1.09
-0.01 (-0.91%)
After-hours: Jun 26, 2026, 7:54 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $26.3M significantly exceed its total debt $8.7M, ensuring strong financial flexibility
Total current assets $39.4M exceed Total current liabilities $37.9M, highlighting excellent liquidity
Debt-to-equity ratio (1.4) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$21.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.04 | 6.05 | 7.0 | |
| Quick ratio | 1.04 | 5.63 | 7.0 | |
| Debt to Equity | 1.43 | 0.30 | 5.0 | |
| Debt to Assets | 0.17 | 1.04 | 8.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 5.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 10M | 832K | 218K | 65K | N/A |
| Gross Profit | 5M | -3M | -3M | -3M | -3M |
| Operating Income | -274M | -135M | -114M | -87M | -84M |
| Net Income | -280M | -135M | -107M | -85M | -85M |
| EBITDA | -269M | -132M | -111M | -84M | -81M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 59.28 | 5.5 |
| Next quarter | N/A | 74.17 | 5.5 |
| Current year | 16551.75 | 50.66 | 10 |
| Next year | 534.83 | 56.92 | 10 |
| Weighted average score | 7.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -622.79 | -566.66 | -10.73 | 3.3 |
| Y/Y | -99.99 | 0.06 | 45.1 | 19.83 | 5.5 |
| 3y average | -78.55 | 31.04 | 48.65 | 24.57 | 7.8 |
| 5y average | 33.3 | 3.7 | 25.95 | 10.55 | 7.8 |
| Weighted average score | 6.1 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |